Long, J.; Huang, Y.; Tang, Z.; Shan, Y.; Feng, D.; Wang, W.; Liu, J.; Huang, Y.; Gu, H.; Guo, D.;
et al. Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance. Antioxidants 2022, 11, 1505.
https://doi.org/10.3390/antiox11081505
AMA Style
Long J, Huang Y, Tang Z, Shan Y, Feng D, Wang W, Liu J, Huang Y, Gu H, Guo D,
et al. Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance. Antioxidants. 2022; 11(8):1505.
https://doi.org/10.3390/antiox11081505
Chicago/Turabian Style
Long, Jing, Yan Huang, Zhengshan Tang, Yali Shan, Dou Feng, Wenqin Wang, Juan Liu, Ying Huang, Hang Gu, Dewei Guo,
and et al. 2022. "Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance" Antioxidants 11, no. 8: 1505.
https://doi.org/10.3390/antiox11081505
APA Style
Long, J., Huang, Y., Tang, Z., Shan, Y., Feng, D., Wang, W., Liu, J., Huang, Y., Gu, H., Guo, D., Yao, R., & Ni, X.
(2022). Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance. Antioxidants, 11(8), 1505.
https://doi.org/10.3390/antiox11081505